Walker Marlan D

SEC source: 0000905148-25-003782 · form4.xml · derivative · entry 1

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,492

Underlying: Common Stock · 67,492 shares

Expires 2035-11-03

F1 · derivative.exercise_date: Underlying shares each vested on November 3, 2025.

SEC source: 0000905148-25-001215 · form4.xml · nonDerivative · entry 1

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,639

SEC source: 0000905148-25-001190 · form4.xml · nonDerivative · entry 2

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,149

SEC source: 0000905148-25-001190 · form4.xml · nonDerivative · entry 1

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,982

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $0.8741 through $0.88, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth.

SEC source: 0000905148-25-000737 · form4.xml · derivative · entry 8

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,733

Underlying: Common Stock · 1,733 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of common stock of the issuer. The RSUs vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025. On February 18, 2025, the reporting person received 1,733 shares of common stock of the issuer in settlement of RSUs, which vested on March 23, 2024.

F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of common stock of the issuer. The RSUs vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025. On February 18, 2025, the reporting person received 1,733 shares of common stock of the issuer in settlement of RSUs, which vested on March 23, 2024.

SEC source: 0000905148-25-000737 · form4.xml · derivative · entry 7

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 770 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 770 shares of common stock of the issuer in settlement of RSUs, which vested on September 29, 2024.

F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 770 shares of common stock of the issuer in settlement of RSUs, which vested on September 29, 2024.

SEC source: 0000905148-25-000737 · form4.xml · derivative · entry 6

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,311 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 2,311 shares of common stock of the issuer in settlement of RSUs, which vested on July 1, 2024.

F2 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 2,311 shares of common stock of the issuer in settlement of RSUs, which vested on July 1, 2024.

SEC source: 0000905148-25-000737 · form4.xml · derivative · entry 5

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,467 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 3,467 shares of common stock of the issuer in settlement of PSUs.

F1 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 3,467 shares of common stock of the issuer in settlement of PSUs.

SEC source: 0000905148-25-000737 · form4.xml · nonDerivative · entry 4

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,846

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000905148-25-000737 · form4.xml · nonDerivative · entry 3

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,113

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000905148-25-000737 · form4.xml · nonDerivative · entry 2

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,343

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000905148-25-000737 · form4.xml · nonDerivative · entry 1

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,032

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-23-057725 · doc4.xml · nonDerivative · entry 3

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,565

F1 · kind: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $2.15 through $2.31, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.

SEC source: 0001209191-23-057725 · doc4.xml · nonDerivative · entry 2

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,115

F1 · kind: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $2.22 through $2.48, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.

SEC source: 0001209191-23-057725 · doc4.xml · derivative · entry 4

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 70,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in full on June 30, 2023.

F4 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in full on June 30, 2023.

SEC source: 0001209191-23-057725 · doc4.xml · nonDerivative · entry 1

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,615

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-23-027361 · doc4a.xml · derivative · entry 5

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,466

Underlying: Common Stock · 1,734 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.

F4 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.

SEC source: 0001209191-23-027361 · doc4a.xml · derivative · entry 4

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,010 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in three equal installments annually, becoming fully vested on March 30, 2023.

F3 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in three equal installments annually, becoming fully vested on March 30, 2023.

SEC source: 0001209191-23-027361 · doc4a.xml · nonDerivative · entry 3

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,615

F2 · kind: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.

SEC source: 0001209191-23-027361 · doc4a.xml · nonDerivative · entry 2

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The beneficially owned shares have been adjusted as the restricted stock units previously reported as settled on April 12, 2023 were not settled on that date. The restricted stock units settled on April 26, 2023.

SEC source: 0001209191-23-027361 · doc4a.xml · nonDerivative · entry 1

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,041

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The beneficially owned shares have been adjusted as the restricted stock units previously reported as settled on April 12, 2023 were not settled on that date. The restricted stock units settled on April 26, 2023.

SEC source: 0001209191-23-024388 · doc4.xml · derivative · entry 9

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,466

Underlying: Common Stock · 1,734 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The vested performance stock units (PSUs) represent PSUs deemed by the compensation committee to be vested at target due to the change in the issuer's business model. The remaining PSUs vest based on the issuer achieving certain revenue milestones over the period from 2021 through 2023. One quarter of the initial PSUs were forfeited based on the failure of the issuer to achieve certain EBITDA milestones for the year ended December 31, 2021. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F6 · derivative.expiration_date: The vested performance stock units (PSUs) represent PSUs deemed by the compensation committee to be vested at target due to the change in the issuer's business model. The remaining PSUs vest based on the issuer achieving certain revenue milestones over the period from 2021 through 2023. One quarter of the initial PSUs were forfeited based on the failure of the issuer to achieve certain EBITDA milestones for the year ended December 31, 2021. Each PSU represents a contingent right to receive one share of common stock of the issuer.

SEC source: 0001209191-23-024388 · doc4.xml · derivative · entry 8

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,466

Underlying: Common Stock · 1,734 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.

F5 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.

SEC source: 0001209191-23-024388 · doc4.xml · derivative · entry 7

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,010 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in three equal installments annually, becoming fully vested on March 30, 2023.

F4 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in three equal installments annually, becoming fully vested on March 30, 2023.

SEC source: 0001209191-23-024388 · doc4.xml · derivative · entry 6

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,030 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The performance stock units (PSUs) vested upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs would have been forfeited. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F3 · derivative.expiration_date: The performance stock units (PSUs) vested upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs would have been forfeited. Each PSU represents a contingent right to receive one share of common stock of the issuer.

SEC source: 0001209191-23-024388 · doc4.xml · nonDerivative · entry 5

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,307

F1 · kind: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $3.63 through $3.71, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.

SEC source: 0001209191-23-024388 · doc4.xml · nonDerivative · entry 4

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,477

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-23-024388 · doc4.xml · nonDerivative · entry 3

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-23-024388 · doc4.xml · nonDerivative · entry 2

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,009

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-23-024388 · doc4.xml · nonDerivative · entry 1

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,999

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-23-012287 · doc4.xml · derivative · entry 1

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in full on June 30, 2023.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in full on June 30, 2023.

F1 · derivative.underlying_shares: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in full on June 30, 2023.

SEC source: 0001209191-23-008817 · doc5.xml · nonDerivative · entry 1

Walker Marlan D · CIK 0001820187 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,969

F1 · kind: This transaction represents a charitable donation.

SEC source: 0001209191-22-060587 · doc4.xml · derivative · entry 7

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 770

Underlying: Common Stock · 388 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs).

F6 · derivative.exercise_date: Subject to the reporting person's continuous service, the RSUs will vest in three equal installments annually, beginning September 29, 2022, becoming fully vested on September 29, 2024.

F6 · derivative.expiration_date: Subject to the reporting person's continuous service, the RSUs will vest in three equal installments annually, beginning September 29, 2022, becoming fully vested on September 29, 2024.

SEC source: 0001209191-22-060587 · doc4.xml · derivative · entry 6

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,311

Underlying: Common Stock · 1,156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs).

F5 · derivative.exercise_date: The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024.

F5 · derivative.expiration_date: The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024.

SEC source: 0001209191-22-060587 · doc4.xml · derivative · entry 5

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,010

Underlying: Common Stock · 1,010 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs).

F4 · derivative.exercise_date: The RSUs vest in three equal installments annually, becoming fully vested on March 30, 2023.

F4 · derivative.expiration_date: The RSUs vest in three equal installments annually, becoming fully vested on March 30, 2023.

SEC source: 0001209191-22-060587 · doc4.xml · nonDerivative · entry 4

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,685

F2 · kind: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $4.66 through $5.41, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.

SEC source: 0001209191-22-060587 · doc4.xml · nonDerivative · entry 3

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,733

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs).

SEC source: 0001209191-22-060587 · doc4.xml · nonDerivative · entry 2

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,345

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs).

SEC source: 0001209191-22-060587 · doc4.xml · nonDerivative · entry 1

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs).

SEC source: 0001209191-22-021795 · doc4.xml · derivative · entry 1

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,000

Underlying: Common Stock · 260,000 shares

Expires not disclosed

F1 · derivative.exercise_date: The performance stock units ("PSUs") vest on April 5, 2025 based the total shareholder return ("TSR") of the issuer over the period from April 1, 2022 to March 31, 2025 and are subject to the continuous service of the reporting person with the issuer. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs, depending on the TSR milestone achieved. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F1 · derivative.expiration_date: The performance stock units ("PSUs") vest on April 5, 2025 based the total shareholder return ("TSR") of the issuer over the period from April 1, 2022 to March 31, 2025 and are subject to the continuous service of the reporting person with the issuer. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs, depending on the TSR milestone achieved. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F1 · derivative.underlying_shares: The performance stock units ("PSUs") vest on April 5, 2025 based the total shareholder return ("TSR") of the issuer over the period from April 1, 2022 to March 31, 2025 and are subject to the continuous service of the reporting person with the issuer. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs, depending on the TSR milestone achieved. Each PSU represents a contingent right to receive one share of common stock of the issuer.

SEC source: 0001209191-22-021210 · doc4.xml · derivative · entry 1

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,000

Underlying: Common Stock · 260,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.

F1 · derivative.underlying_shares: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.

SEC source: 0001209191-22-021208 · doc4.xml · derivative · entry 1

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,000

Underlying: Common Stock · 260,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.

F1 · derivative.underlying_shares: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.

SEC source: 0001209191-22-018682 · doc4.xml · derivative · entry 2

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 230,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On March 14, 2022, the reporting person received 230,000 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on December 13, 2021.

F2 · shares: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

F3 · derivative.exercise_date: The RSUs vested on December 13, 2021.

F3 · derivative.expiration_date: The RSUs vested on December 13, 2021.

SEC source: 0001209191-22-018682 · doc4.xml · nonDerivative · entry 1

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,908

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On March 14, 2022, the reporting person received 230,000 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on December 13, 2021.

SEC source: 0001209191-21-058493 · doc4.xml · derivative · entry 5

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 120,000 shares

Expires 2028-03-15

F3 · kind: Stock options exchanged for RSUs pursuant to the Option Exchange Program.

F3 · shares: Stock options exchanged for RSUs pursuant to the Option Exchange Program.

F7 · derivative.exercise_date: Underlying shares were subject to vesting as follows: 40,000 shares on the first anniversary date of the grant, 40,000 shares on the second anniversary date of the grant, and 40,000 shares on the third anniversary date of the grant.

F7 · derivative.expiration_date: Underlying shares were subject to vesting as follows: 40,000 shares on the first anniversary date of the grant, 40,000 shares on the second anniversary date of the grant, and 40,000 shares on the third anniversary date of the grant.

SEC source: 0001209191-21-058493 · doc4.xml · derivative · entry 4

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2027-03-14

F3 · kind: Stock options exchanged for RSUs pursuant to the Option Exchange Program.

F3 · shares: Stock options exchanged for RSUs pursuant to the Option Exchange Program.

F6 · derivative.exercise_date: Underlying shares were subject to vesting as follows: 8,333 shares on the first anniversary date of the grant, 8,333 shares on the second anniversary date of the grant, and 8,334 shares on the third anniversary date of the grant.

F6 · derivative.expiration_date: Underlying shares were subject to vesting as follows: 8,333 shares on the first anniversary date of the grant, 8,333 shares on the second anniversary date of the grant, and 8,334 shares on the third anniversary date of the grant.

SEC source: 0001209191-21-058493 · doc4.xml · derivative · entry 3

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 150,000 shares

Expires 2026-09-22

F3 · kind: Stock options exchanged for RSUs pursuant to the Option Exchange Program.

F3 · shares: Stock options exchanged for RSUs pursuant to the Option Exchange Program.

F5 · derivative.exercise_date: Underlying shares were subject to vesting as follows: 50,000 shares on the first anniversary date of the grant, 50,000 shares on the second anniversary date of the grant, and 50,000 shares on the third anniversary date of the grant.

F5 · derivative.expiration_date: Underlying shares were subject to vesting as follows: 50,000 shares on the first anniversary date of the grant, 50,000 shares on the second anniversary date of the grant, and 50,000 shares on the third anniversary date of the grant.

SEC source: 0001209191-21-058493 · doc4.xml · derivative · entry 2

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2025-06-04

F3 · kind: Stock options exchanged for RSUs pursuant to the Option Exchange Program.

F3 · shares: Stock options exchanged for RSUs pursuant to the Option Exchange Program.

F4 · derivative.exercise_date: Underlying shares were subject to vesting as follows: 50,000 shares on the first anniversary date of the grant, and 50,000 shares on the second anniversary date of the grant.

F4 · derivative.expiration_date: Underlying shares were subject to vesting as follows: 50,000 shares on the first anniversary date of the grant, and 50,000 shares on the second anniversary date of the grant.

SEC source: 0001209191-21-058493 · doc4.xml · derivative · entry 1

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,797

Underlying: Common Stock · 57,797 shares

Expires not disclosed

F1 · shares: Restricted stock units (RSUs) issued pursuant to the Issuer's stock option exchange program approved by stockholders at the Issuer's 2021 annual meeting (the "Option Exchange Program"). Each RSU represents a contingent right to receive one share of common stock of the Issuer.

F2 · derivative.exercise_date: Subject to the reporting person's continuous service, the RSUs will vest in three equal installments annually, beginning September 29, 2022, becoming fully vested on September 29, 2024.

F2 · derivative.expiration_date: Subject to the reporting person's continuous service, the RSUs will vest in three equal installments annually, beginning September 29, 2022, becoming fully vested on September 29, 2024.

SEC source: 0001387131-21-007117 · ownership.xml · derivative · entry 2

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,333

Underlying: Common Stock · 173,333 shares

Expires not disclosed

F2 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024.

F2 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024.